Campos Capital Investments, Inc.

Campos Capital Investments, Inc. trades under the consumer-facing banner Erozul and sells small-format electronic wellness devices—predominantly USB-rechargeable personal massagers, red-light therapy pods, and pulse-relief patches. Price points sit in the mid-range tier: most SKUs fall between US $49 and US $149, with a handful of professional-grade bundles touching US $249. Distribution is online-only through Erozul.com and Amazon marketplace storefronts; no retail partners or company-owned stores are operated. The brand’s distinction is medical-device aesthetics at consumer price points: anodized aluminum housings, FDA-registered Class II OTC indications, and firmware-updatable control chips. Flagship lines “Erozul Pro” and “RecoverRx” bundle TENS, EMS, and 660 nm red-light in one pocket-sized unit—products that routinely rank in Amazon’s top-20 pain-relief devices sub-category. All units ship with lifetime app updates and a no-receipt 24-month replacement warranty, practices still uncommon among direct-to-consumer gadget brands. Primary buyers are 25-45-year-old urban professionals who CrossFit, cycle, or run and want drug-free recovery they can toss in a gym bag. The value set is data-driven self-care: users track session minutes in the companion app, export readouts to Apple Health, and post recovery stats on Strava—behaviors Erozul encourages with monthly leaderboard challenges. Competition comes from two directions: budget Amazon sellers offering US $20 knock-offs lacking certifications, and premium sports-medicine brands selling US $300+ units through physical therapy clinics. Erozul differentiates by bridging the gap—clinical-grade features at half the price of premium players while using firmware and warranty depth to outclass low-cost entrants.